Crouse Hospital has received the American Heart Association/American Stroke Association’s Get With The Guidelines-Stroke ‘Gold Plus’ Quality Achievement Award for 2013. The award recognizes Crouse’s commitment and success in implementing high standards of care for stroke patients according to evidence-based guidelines.
To receive the award, Crouse achieved of 85 percent or higher adherence to all Get With The Guidelines-Stroke Quality Achievement indicators for two or more consecutive 12-month intervals and achieved 75 percent or higher compliance with six of 10 Get With The Guidelines-Stroke Quality Measures, which are reporting initiatives to measure quality of care.
These measures include aggressive use of medications, such as antithrombotics, anticoagulation therapy, deep vein thrombosis prophylaxis, cholesterol reducing drugs and smoking cessation, all aimed at reducing death and disability and improving the lives of stroke patients.
In addition to the Get With The Guideline-Stroke award Crouse has also been recognized as a recipient of the association’s Target: Stroke Honor Roll, for improving stroke care. Over the past quarter, at least 50 percent of the hospital’s eligible ischemic stroke patients have received tissue plasminogen activator, or tPA, within 60 minutes of arriving at the hospital (known as ‘door-to-needle’ time). A thrombolytic, or clot-busting agent, tPA is the only drug approved by the U.S. Food and Drug Administration for the urgent treatment of ischemic stroke.
“With a stroke, time lost is brain lost, and this award demonstrates our focus on and commitment to being one of the top hospitals in the country for providing aggressive, proven stroke care,” says Ron Stahl, MD, chief medical officer for Crouse Hospital. Crouse has been a New York State Department of Health-designated stroke center since 2007.